WTO MC13: TRIPS Issues and Technology Transfer by Viviana Munoz Tellez, Nirmalya Syam
This Policy Brief discusses issues concerning trade, intellectual property, and technology transfer that are most relevant for consideration at the 13th World Trade (more...)
Inputs for the analytical study on the impact of loss and damage from the adverse effects of climate change on the full enjoyment of human rights, pursuant to Human Rights Council Resolution 53/6 on human rights and climate change31 January 2024
The adverse impacts (more...)
How the EU’s Carbon Border Adjustment Mechanism discriminates against foreign producers By Peter Lunenborg and Vahini Naidu
In April 2023, the European Parliament adopted the final text of the Carbon Border Adjustment Mechanism (CBAM) and revisions to the European (more...)
South Centre Statement to the 7th meeting of the WHO Working Group on Amendments to the International Health Regulations (2005)6 February 2024
The South Centre urges the WGIHR to ensure that equity issues are substantially addressed in the process of (more...)
Desafíos actuales y posibles escenarios futuros de la salud mundial By Germán Velásquez
Hace cuatro décadas los principales actores en la salud global eran la Organización Mundial de la salud (OMS), el Fondo de las Naciones Unidas para la Infancia (UNICEF) y (more...)
Pautas para el examen de patentes sobre anticuerpos monoclonales Por Juan Correa, Catalina de la Puente, Ramiro Picasso y Constanza Silvestrini
La investigación tiene como objetivo conocer el estado de las solicitudes de patente en materia de anticuerpos (more...)
A Decade of the Indian Advance Pricing Agreement Programme: Achievements and ChallengesBy Priyanka Mashelkar and Apoorv Tiwari
India’s Advance Pricing Agreement (APA) programme was introduced in 2012 with the objective of reducing transfer pricing disputes and (more...)
WHO Executive Board 154th SessionSouth Centre Statement on Agenda Item 13: Antimicrobial Resistance
Increased global collaboration is needed to contain emergence and spread of drug-resistant pathogens.
(more...)
TRIPS Waiver Decision for Equitable Access to Medical Countermeasures in the Pandemic: COVID-19 Diagnostics and Therapeutics By Nirmalya Syam and Muhammad Zaheer Abbas, PhD
The Marrakesh Agreement Establishing the World Trade Organization (WTO) allows WTO Members to (more...)
Implementing the Doha Declaration in OAPI Legislation: Do Transition Periods Matter?By Patrick Juvet Lowé Gnintedem
The Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement) provided for a number of transition periods allowing (more...)
Statement for the Third South Summit of the Group of 77 and ChinaKampala, Uganda21-23 January 2024
South Centre stressed that the theme of the G77 Summit ‘Leaving No One Behind ’ reflects the urgent needs and aspirations of the Global South towards (more...)
Statement for the 19th Summit of Heads of State and Government of the Non-Aligned MovementKampala, Uganda19-20 January 2024
The South Centre addressed the 19th Summit of NAM, and highlighted that international (more...)
